drugset
drugset / Trial / NCT00962585

Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients

NCT00962585 ↗

Phase 2 Completed 169 enrolled Ausio Pharmaceuticals, LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and effectiveness of S-equol in menopausal patients with hot flushes and night sweats.

Timeline

Start
2010-06
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AUS-131 Small molecule 10 mg —
Subject AUS-131 Small molecule 50 mg —
Subject AUS-131 Small molecule 150 mg —

Indications

No indication recorded.